Biotricity Confirms Support of Progressive Changes in Telemedicine Healthcare Policy

Biotricity Inc., a medical diagnostic and consumer healthcare technology company, is once again acknowledging the importance of telemedicine by announcing its support of the proposed changes in healthcare policy and its expansion into healthcare practices.
“Biotricity believes that the rise of telemedicine at the federal and state levels points to a healthcare shift that promotes remote care delivery,” an emailed statement to MHW reads.

This direction, we’re told, could create opportunities for remote patient monitoring solutions that can be integrated within telemedicine.

The nationwide telehealth coverage bill called the Medicare Telehealth Parity Act of 2017 is one of several new federal bills currently under consideration. Designed to introduce an incremental, though significant, expansion of coverage for telehealth services under the Medicare program, the bipartisan Act is sponsored by Representative Mike Thompson (D-CA), with seven co-sponsors to date. If enacted in its current form, it could modernize the way Medicare reimburses telehealth services by expanding the number of qualifying geographic locations, and expanding coverage of telehealth services.

If you’re not familiar, Biotricity’s remote patient monitoring device platform aligns with telemedicine and can be integrated with telehealth solutions.

“The legislative progress towards telemedicine is an excellent driver of health technology innovation and, more importantly, improves patient care for all individuals,” explains Biotricity CEO and Founder Waqaas Al-Siddiq. “With more freedom, integrating telemedicine technologies into healthcare delivery is simplified, driving down costs and facilitating widespread access to care—especially remote care.”

This post was written by:

- who has written 2293 posts on mHealthWatch.

Contact the author